Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

about

Hepatorenal syndrome: the clinical impact of vasoactive therapy.Review article: the role of the microcirculation in liver cirrhosis.

P2860

Q47773498-D7986D9E-68EA-4369-B101-753F7DC45EF4 Q47812599-59475755-2501-421C-B771-027708EF08C9

P2860

Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

Item

http://www.wikidata.org/entity/Q39323851

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

@en

Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

@nl

type

Item

label

Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

@en

Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

@nl

prefLabel

Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

@en

Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

@nl

P1476

Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

@en

P2093

Elisabeth Krones

http://www.w3.org/2001/XMLSchema#string

Theresa Bucsics

http://www.w3.org/2001/XMLSchema#string

P2860

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis

Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver

Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.

Serum cystatin C as an endogenous marker of the renal function--a review.

Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.

Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary center

Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.

MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.

P304

127-137

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/GASTRO/GOX009

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28533910

http://www.w3.org/2001/XMLSchema#string

P921

liver cirrhosis

P932

5421450

http://www.w3.org/2001/XMLSchema#string

Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

about

P2860

P2860

Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932